Novel Plasma Kallikrein Inhibitors for Treating Hereditary Angioedema, Diabetic Macular Edema, and Diabetic Retinopathy
ACS Med Chem Lett
.
2022 Mar 4;13(4):528-529.
doi: 10.1021/acsmedchemlett.2c00085.
eCollection 2022 Apr 14.
Author
Ram W Sabnis
1
Affiliation
1
Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
PMID:
35450363
PMCID:
PMC9014518
DOI:
10.1021/acsmedchemlett.2c00085
No abstract available
Publication types
Editorial